Establishment and characterization of a novel dedifferentiated liposarcoma cell line, NDDLS-1

Pathology International

Volumn 61, Issue 8, 2011, Pages 461-468

  Ariizumi, Takashi ^a   Ogose, Akira ^a   Kawashima, Hiroyuki ^a   Hotta, Tetsuo ^a   Li, Guidong ^a   Xu, Yongjun ^a   Hirose, Takanori ^b   Endo, Naoto ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Dedifferentiated liposarcoma; Inflammatory cytokine; Inflammatory malignant fibrous histiocytoma; Leukocytosis; Paraneoplastic syndrome

Indexed keywords

CYCLIN DEPENDENT KINASE 4; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CLINICAL TRIAL; CONTROLLED STUDY; CYTOGENETICS; EOSINOPHIL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LEUKOCYTOSIS; LIPOSARCOMA; MALE; MOUSE; NDDLS 1 CELL; NEUTROPHIL; NONHUMAN; PLEOMORPHIC ADENOMA; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RING CHROMOSOME; TUMOR CELL; TUMOR GROWTH;

AGED, 80 AND OVER; ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CYCLIN-DEPENDENT KINASE 4; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERLEUKIN-6; LEUKOCYTOSIS; LIPOSARCOMA; LUNG NEOPLASMS; MALE; MICE; MICE, SCID; PROTO-ONCOGENE PROTEINS C-MDM2; RNA, NEOPLASM; SOFT TISSUE NEOPLASMS; SPECTRAL KARYOTYPING; TRANSPLANTATION, HETEROLOGOUS;

EID: 79960728671     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2011.02683.x     Document Type: Article

References (27)

1. Dei Tos AP. Liposarcoma: New entities and evolving concepts. Ann Diagn Pathol 2000; 4: 252-66.
2. Fletcher CDM, Unni KK. Pathology and Genetics: Tumors of Soft Tissue and Bone. World Health Organization Classification of Tumors. Lyon: IARC Press, 2002.
3. Henricks WH, Chu YC, Goldblum JR, Weiss SW. Dedifferentiated liposarcoma: A clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation. Am J Surg Pathol 1997; 21: 271-81.
4. Weiss SW, Goldblum JR. Enzinger & Weiss's Soft Tissue Tumors, 5th edn. Philadelphia, PA: Mosby Elsevier, 2008.
5. Kuhnen C, Mentzel T, Sciot R, Lehnhardt M, Homann HH, Debiec-Rychter M. Dedifferentiated liposarcoma with extensive lymphoid component. Pathol Res Prac 2005; 201: 347-53.
6. Hisaoka M, Tsuji S, Hashimoto H, Aoki T, Uriu K. Dedifferentiated liposarcoma with an inflammatory malignant fibrous histiocytoma-like component presenting a leukemoid reaction. Pathol int 1997; 47: 642-46.
7. Sakamoto A, Matono H, Yoshida T etal. Dedifferentiated liposarcoma with leukocytosis. A case report of G-CSF-producing soft-tissue tumors, possible association with undifferentiated liposarcoma lineage. World J Surg Oncol 2007; 5: 131.
8. Nasser SM, Choudry UH, Nielsen GP, Ott MJ. A leukemoid reaction in a patient with a dedifferentiated liposarcoma. Surgery 2001; 129: 765-7.
9. Isoda M, Yasumoto S. Eosinophil chemotactic factor derived from a malignant fibrous histiocytoma. Clin Exp Dermatol 1986; 11: 253-9.
10. Kawashima H, Ogose A, Gu W etal. Establishment and characterization of a novel myxofibrosarcoma cell line. Cancer Genet Cytogenet 2005; 161: 28-35.
11. Seabright M. A rapid banding technique for human chromosomes. Lancet 1971; 50: 971-2.
12. Shaffer LG, Slovak ML, Campbell LJ. An International System for Human Cytogenetic Nomenclature. Basel: S. Karger, 2009.
13. Shimada S, Ishizawa T, Ishizawa K, Matsumura T, Hasegawa T, Hirose T. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers. Hum Pathol 2006; 37: 1123-9.
14. Nishio J, Iwasaki H, Ishiguro M etal. Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-1: Conventional and molecular cytogenetic characterization. Int J Oncol 2003; 22: 535-42.
15. Hamada T, Komiya S, Hiraoka K, Zenmyo M, Morimatsu M, Inoue A. IL-6 in a pleomorphic type of malignant fibrous histiocytoma presenting high fever. Hum Pathol 1998; 29: 758-61.
16. Mayumi E, Okuno T, Ogawa T etal. Malignant fibrous histiocytoma of soft tissue producing granulocyte colony-stimulating factor. Intern Med 2001; 40: 536-40.
17. Melhem MF, Meisler AI, Saito R, Finley GG, Hockman HR, Koski RA. Cytokines in inflammatory malignant fibrous histiocytoma presenting with leukemoid reaction. Blood 1993; 82: 2038-44.
18. Pedeutour F, Suijkerbuijk RF, Forus A etal. Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma. Genes Chromosomes Cancer 1994; 10: 85-94.
19. Rosai J, Akerman M, Dal Cin P etal. Combined morphologic and karyotypic study of 59 atypical lipomatous tumors. Evaluation of their relationship and differential diagnosis with other adipose tissue tumors (a report of the CHAMP Study Group). Am J Surg Pathol 1996; 20: 1182-9.
20. Pedeutour F, Forus A, Coindre JM etal. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 1999; 24: 30-41.
21. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992; 358: 80-3.
22. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992; 69: 1237-45.
23. Bockstaele L, Coulonval K, Kooken H, Paternot S, Roger PP. Regulation of CDK4. Cell Div 2006; 1: 25.
24. Sherr CJ. Cancer cell cycles. Science 1996; 274: 1672-7.
25. Coindre JM, Hostein I, Maire G etal. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: Histological review, genomic profile, and MDM2 and CDK4 status favour a single entity. J Pathol 2004; 203: 822-30.
26. Vassilev LT. MDM2 inhibitors for cancer therapy. Trends Mol Med 2007; 13: 23-31.
27. Michaud K, Solomon DA, Oermann E etal. Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts. Cancer Res 2010; 70: 3228-38.